Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000892569-03-001144
Filing Date
2003-04-30
Accepted
2003-04-30 16:50:31
Documents
13
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A a87286a1e10vkza.htm 10-K/A 1139805
3 EXHIBIT 10.39 a87286a1exv10w39.txt EX-10.39 55136
4 EXHIBIT 10.40 a87286a1exv10w40.txt EX-10.40 4604
5 EXHIBIT 10.41 a87286a1exv10w41.txt EX-10.41 1791
6 EXHIBIT 10.42 a87286a1exv10w42.txt EX-10.42 57931
7 EXHIBIT 10.43 a87286a1exv10w43.txt EX-10.43 52525
8 EXHIBIT 10.45 a87286a1exv10w45.txt EX-10.45 5484
9 EXHIBIT 10.46 a87286a1exv10w46.txt EX-10.46 5100
10 EXHIBIT 23.1 a87286a1exv23w1.txt EX-23.1 1418
11 EXHIBIT 99.1 a87286a1exv99w1.txt EX-99.1 1109
12 EXHIBIT 99.2 a87286a1exv99w2.txt EX-99.2 1116
14 GRAPHIC a87286a1a8728603.gif GRAPHIC 12514
15 GRAPHIC a87286a1a8728604.gif GRAPHIC 7186
  Complete submission text file 0000892569-03-001144.txt   1348776
Mailing Address 15279 ALTON PARKWAY 100 IRVINE CA 92618
Business Address 15279 ALTON PARKWAY 100 IRVINE CA 92618 9497886000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31255 | Film No.: 03673597
SIC: 2835 In Vitro & In Vivo Diagnostic Substances